tirzepatide gip glp 1 dual action drops Compound Weight Management & Slimming -

Pharmacy partners are referenced as qualified but are not publicly named or listed by the platform

Stopping Mounjaro may result in weight gain or elevated blood sugar levels, as it helps regulate both.

The newer Foundayo (orforglipron), FDA approved April 2026, is the first oral GLP-1 with no food or water restrictions although average weight loss is lower than the injectables (11% vs 15-20%)

Variations in antioxidant enzymes were also observed in many studies

Ozempic or Trulicity and children Trulicity may be used to manage blood sugar levels in children ages 10 years and older who have type 2 diabetes

They also found that bariatric surgery affected personal relationships